We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
British American Tobacco Plc | LSE:BATS | London | Ordinary Share | GB0002875804 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-23.00 | -0.85% | 2,677.00 | 2,673.00 | 2,674.00 | 2,689.00 | 2,672.00 | 2,684.00 | 1,689,323 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Cigarettes | 27.72B | -14.37B | -6.4827 | -4.12 | 59.84B |
Date | Subject | Author | Discuss |
---|---|---|---|
14/10/2021 13:22 | RBC RAISES BRITISH AMERICAN TOBACCO PRICE TARGET TO 3,300 (3,200) PENCE - 'OUTPERFORM' | garycook | |
14/10/2021 09:33 | Write up in the times todayUS Food and Drug Administration gives green light for British American Tobacco's e-cigarettesAlex RalphThursday October 14 2021, 12.01am BST, The TimesThe US Food and Drug Administration said BAT's data showed that three of its tobacco-flavoured Vuse Solo products could benefit addicted adult smokersThe US Food and Drug Administration said BAT's data showed that three of its tobacco-flavoured Vuse Solo products could benefit addicted adult smokersMARK STEHLE/APAn American regulator has authorised the marketing of several of British American Tobacco's e-cigarette products, making them the first vaping products to be granted clearance amid an industry-wide review into their appeal to younger consumers.The US Food and Drug Administration said BAT's data showed that three of its tobacco-flavoured Vuse Solo products could benefit addicted adult smokers who switched to them "by reducing their exposure to harmful chemicals". However, it denied BAT's request to sell other flavoured Vuse products and is evaluating a proposal to keep selling a menthol version.The FDA is working through a series of applications, including from Juul, the American e-cigarette company, which has faced a clampdown over the marketing of flavoured products. The products under review have already been sold in the United States, but need FDA approval for marketing to continue.Tobacco manufacturers have invested heavily in e-cigarettes as they try to diversify away from toxic combustible tobacco products.Mitch Zeller, director of the FDA's centre for tobacco products, said that the authorisations were an "important step toward ensuring all new tobacco products undergo the FDA's robust, scientific pre-market evaluation".He added: "We will monitor the marketing of the products, including whether the company fails to comply with any regulatory requirements or if credible evidence emerges of significant use by individuals who did not previously use a tobacco product, including youth. We will take action as appropriate."A national survey found that 10 per cent of high school students who used e-cigarettes named Vuse as their usual brand. The FDA said the data reinforced its decision to authorise the tobacco-flavour products because they were "less appealing to youth".BAT said the decision underscored "years of research dedicated to ensuring that adult nicotine consumers aged 21-plus have access to innovative and potentially less harmful alternatives to traditional tobacco products". A spokesman said that the denial orders related to five flavours not on sale.Shares in BAT rose 30p, or 1.2 per cent, to £25.69½. | tole | |
14/10/2021 08:04 | Started ok up .5% | car1pet | |
14/10/2021 07:38 | 2% rise today anybody??? Markets looking good atm.. | plastow | |
13/10/2021 22:25 | Nice👍 | gemlotte55 | |
13/10/2021 21:23 | Wow, what percentage rise was that please cat1pet? | gemlotte55 | |
13/10/2021 21:08 | BTI closed at $35.56 which is approx 2600p so lets see what tomorrow brings | car1pet | |
13/10/2021 13:58 | I will hold off purchasing here now until after the UK budget on 27th October.Cigs always get clobbered with more tax here, and it seems to have a disproportionate affect on the overall share price considering BATs sells in hundreds of countries globally. | redbaron10 | |
13/10/2021 13:49 | Berny3 I agree,but when is the market going to appreciate and recognise value stocks (imho) like this? Market sentiment is all towards tech stocks and breakneck growth stories.When,if ever,is demand for shares like this going to improve? What is it going to take? Good results.....result share price falls,ex-dividend ......result share price takes another whole leg down.6%,7%,8% yield thresholds have been broken and still more selling.I'd be interested in a technicians,chartist | redbaron10 | |
13/10/2021 13:33 | Looking better now the US ADR is up 1.09% in the pre-market so hopefully the UK will follow the US | car1pet | |
13/10/2021 11:31 | Barclays has issued "overweight" recommendation today with target price of 3300p | car1pet | |
13/10/2021 11:09 | Was really tempted on buying a few more today but see what the reaction is like later.. | plastow | |
13/10/2021 10:34 | As we approach 2.30 today before the US market opens check out the pre-market price on BTI and we will get a sense of where the UK price is going. Hopefully significantly upwards | car1pet | |
13/10/2021 10:01 | I remember back in the 90's when the lawsuits were out against BAT and the share price being pummelled down in to the single pounds. the share price reversed those losses. I think it will turn around here too. I think the post above (redbarron) brings in some interesting points. One for me is the pension funds not buying due to investment objectives. Value in the company is not taking away if demand for the shares falls away. Therefore I feel that the current price represents long term opportunity. | berny3 | |
13/10/2021 09:33 | Link to CNBC report. seems as if BAT is in the box seat. Juul not approved as yet. Seems as if because the Vuse product has no flavours its been approved. Anti smoker don't like the decision which is usually good news for BAT | car1pet | |
13/10/2021 09:14 | I just checked out the Seeking alpha message board. Without exception all posters say the FDA approval is a massive positive for BATS/BTI. All are buying so lets wait and see. | car1pet | |
13/10/2021 09:01 | Price is recovering a bit. For bottom fishers this could be a good time to buy. I don't have any spare cash at the moment | car1pet | |
13/10/2021 08:52 | Looks as if I was wrong again. Vuse approved by FDA and price falls 1%. Hard to understand this. Also news BAT is pulling out of Myanmar which will affect revenue and I guess there is a cost of removal ie closing manufacturing etc. This may have caused the drop | car1pet | |
13/10/2021 08:43 | Is this why the drop? "However, 10 unspecified Vuse Solo brand flavored ENDS products were denied marketing authorization by the FDA." I expected share price to react better than this | crt131 | |
13/10/2021 08:05 | Positive news and shows BATS ability to change the business. | vfast | |
13/10/2021 00:00 | Thanks salver2. British American Tobacco (BTI -0.4%) subsidiary R.J. Reynolds receives authorization from the FDA to sell its Vuse Solo e-cigarette and its associated tobacco-flavored pods in the United States. The marketing granted order includes authorization for Vuse Solo Power Unit, Vuse Replacement Cartridge Original 4.8% G1 and Vuse Replacement Cartridge Original 4.8% G2. However, 10 unspecified Vuse Solo brand flavored ENDS products were denied marketing authorization by the FDA. The FDA said that the benefits to current smokers who switched to the e-cigarettes should outweigh harmful impacts to youth. R.J. Reynolds must follow requirements focused on limiting youth exposure and access to its products. | philanderer | |
12/10/2021 23:44 | Bat Vuse just approved by The FDA. - must be good news | salver2 | |
12/10/2021 18:08 | Even with all this ESG stuff supposedly putting off the institutions and pension funds, when you actually check the top 10 holdings of many the income paying trusts and funds there are still quite a few that hold bats and Imb right up their with their largest holdings. Large dependable quarterly dividends too good to ignore for many imo. | krowelet | |
12/10/2021 17:39 | Interesting analyse Redbaron. I just bought in this week at 2,537 and 2,527 and was attracted by the 8.5% yield however the company has restructured parts of the business which appears to signal growth. Plus, in third world countries smoking has increased. Still a very profitable business and they have increased their dividends over the last 4 years. Like you say no one has a crystal ball and sentiment does play a factor however BATS appears to be working hard to change its image. Time will tell! | vfast |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions